Culturing: Agro_ML11, 96 deep-well microplate; 0.8 mL volume, Aerobic, at 28 (C), shaken=700 rpm
| Pathway | #Steps | #Present | #Specific |
|---|
| L-glutamate degradation I | 1 | 1 | 1 |
| cis-cyclopropane fatty acid (CFA) biosynthesis | 1 | 1 | 1 |
| L-asparagine degradation I | 1 | 1 | 1 |
| L-proline degradation I | 3 | 3 | 2 |
| proline to cytochrome bo oxidase electron transfer | 2 | 2 | 1 |
| adenosine deoxyribonucleotides de novo biosynthesis I | 2 | 2 | 1 |
| guanosine deoxyribonucleotides de novo biosynthesis I | 2 | 2 | 1 |
| UDP-α-D-glucose biosynthesis | 2 | 2 | 1 |
| glycogen degradation I | 8 | 6 | 4 |
| guanosine deoxyribonucleotides de novo biosynthesis II | 4 | 3 | 2 |
| adenosine deoxyribonucleotides de novo biosynthesis II | 4 | 3 | 2 |
| pseudouridine degradation | 2 | 1 | 1 |
| arsenate detoxification III | 2 | 1 | 1 |
| sterculate biosynthesis | 2 | 1 | 1 |
| pentose phosphate pathway (oxidative branch) I | 3 | 3 | 1 |
| adenine salvage | 3 | 3 | 1 |
| L-alanine degradation II (to D-lactate) | 3 | 3 | 1 |
| sorbitol biosynthesis II | 3 | 3 | 1 |
| glycogen degradation II | 6 | 5 | 2 |
| L-arginine degradation I (arginase pathway) | 3 | 2 | 1 |
| L-asparagine degradation III (mammalian) | 3 | 2 | 1 |
| starch degradation I | 3 | 1 | 1 |
| ethene biosynthesis IV (engineered) | 3 | 1 | 1 |
| superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis (E. coli) | 14 | 12 | 4 |
| superpathway of adenosine nucleotides de novo biosynthesis II | 7 | 6 | 2 |
| glycogen biosynthesis I (from ADP-D-Glucose) | 4 | 4 | 1 |
| superpathway of guanosine nucleotides de novo biosynthesis II | 8 | 7 | 2 |
| heme b biosynthesis II (oxygen-independent) | 4 | 3 | 1 |
| superpathway of L-aspartate and L-asparagine biosynthesis | 4 | 3 | 1 |
| sucrose biosynthesis II | 8 | 5 | 2 |
| starch degradation III | 4 | 2 | 1 |
| starch degradation V | 4 | 2 | 1 |
| arsenic detoxification (bacteria) | 4 | 2 | 1 |
| ethene biosynthesis II (microbes) | 4 | 1 | 1 |
| L-ascorbate biosynthesis VI (plants, myo-inositol pathway) | 4 | 1 | 1 |
| glycogen biosynthesis II (from UDP-D-Glucose) | 4 | 1 | 1 |
| pyrimidine deoxyribonucleotides de novo biosynthesis I | 9 | 9 | 2 |
| pyrimidine deoxyribonucleotides de novo biosynthesis III | 9 | 8 | 2 |
| superpathway of adenosine nucleotides de novo biosynthesis I | 5 | 5 | 1 |
| sucrose degradation II (sucrose synthase) | 5 | 4 | 1 |
| glucose and glucose-1-phosphate degradation | 5 | 4 | 1 |
| mannitol cycle | 5 | 4 | 1 |
| starch biosynthesis | 10 | 6 | 2 |
| glucose degradation (oxidative) | 5 | 2 | 1 |
| N-(1-deoxy-D-fructos-1-yl)-L-asparagine degradation | 5 | 2 | 1 |
| L-ascorbate degradation V | 5 | 1 | 1 |
| Salmonella enterica serotype O:3,10 O antigen biosynthesis | 5 | 1 | 1 |
| superpathway of guanosine nucleotides de novo biosynthesis I | 6 | 6 | 1 |
| superpathway of UDP-glucose-derived O-antigen building blocks biosynthesis | 6 | 5 | 1 |
| superpathway of heme b biosynthesis from uroporphyrinogen-III | 6 | 4 | 1 |
| L-ascorbate biosynthesis IV (animals, D-glucuronate pathway) | 6 | 3 | 1 |
| arsenate detoxification I | 6 | 3 | 1 |
| arsenic detoxification (plants) | 6 | 2 | 1 |
| Salmonella enterica serotype O:9,46 O antigen biosynthesis | 6 | 1 | 1 |
| Salmonella enterica serotype O:9 O antigen biosynthesis | 6 | 1 | 1 |
| Salmonella enterica serotype O:2 O antigen biosynthesis | 6 | 1 | 1 |
| (5R)-carbapenem carboxylate biosynthesis | 6 | 1 | 1 |
| Porphyromonas gingivalis O-LPS antigen biosynthesis | 6 | 1 | 1 |
| Salmonella enterica serotype O:4 O antigen biosynthesis (group B1) | 6 | 1 | 1 |
| superpathway of purine nucleotides de novo biosynthesis II | 26 | 23 | 4 |
| pyrimidine deoxyribonucleotides de novo biosynthesis IV | 7 | 6 | 1 |
| L-Nδ-acetylornithine biosynthesis | 7 | 5 | 1 |
| stachyose degradation | 7 | 4 | 1 |
| L-ascorbate biosynthesis VIII (engineered pathway) | 7 | 3 | 1 |
| L-ascorbate degradation II (bacterial, aerobic) | 7 | 2 | 1 |
| 4-aminobutanoate degradation V | 7 | 2 | 1 |
| L-glutamate degradation XI (reductive Stickland reaction) | 7 | 1 | 1 |
| pentose phosphate pathway | 8 | 8 | 1 |
| L-citrulline biosynthesis | 8 | 7 | 1 |
| pyrimidine deoxyribonucleotides biosynthesis from CTP | 8 | 7 | 1 |
| glycogen biosynthesis III (from α-maltose 1-phosphate) | 8 | 2 | 1 |
| Salmonella enterica serotype O:8 O antigen biosynthesis | 8 | 2 | 1 |
| superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis | 18 | 17 | 2 |
| Entner-Doudoroff pathway III (semi-phosphorylative) | 9 | 7 | 1 |
| sucrose biosynthesis I (from photosynthesis) | 9 | 6 | 1 |
| Entner-Doudoroff pathway II (non-phosphorylative) | 9 | 5 | 1 |
| 3,8-divinyl-chlorophyllide a biosynthesis II (anaerobic) | 9 | 2 | 1 |
| Salmonella enterica serotype O:9,46,27 O antigen biosynthesis | 9 | 1 | 1 |
| L-glutamate degradation V (via hydroxyglutarate) | 10 | 4 | 1 |
| superpathway of purine nucleotides de novo biosynthesis I | 21 | 21 | 2 |
| colanic acid building blocks biosynthesis | 11 | 11 | 1 |
| superpathway of histidine, purine, and pyrimidine biosynthesis | 46 | 42 | 4 |
| superpathway of L-citrulline metabolism | 12 | 9 | 1 |
| arsenic detoxification (yeast) | 12 | 3 | 1 |
| folate transformations I | 13 | 8 | 1 |
| superpathway of purine nucleotide salvage | 14 | 13 | 1 |
| succinoglycan biosynthesis | 14 | 10 | 1 |
| superpathway of glucose and xylose degradation | 17 | 16 | 1 |
| type I lipoteichoic acid biosynthesis (S. aureus) | 17 | 5 | 1 |
| superpathway of anaerobic sucrose degradation | 19 | 13 | 1 |
| methylaspartate cycle | 19 | 12 | 1 |
| superpathway of bacteriochlorophyll a biosynthesis | 26 | 6 | 1 |
| mycolate biosynthesis | 205 | 21 | 3 |
| superpathway of mycolate biosynthesis | 239 | 22 | 3 |